Smith & Nephew plc (SN.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Smith & Nephew plc
Address
Building 5
Watford, WD18 8YE
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1923 477 100
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
17349
First IPO Date
July 01, 1988
Key Executives
| Name | Title | Pay | Year Born |
| Deepak S. Nath | Chief Executive Officer & Director | 3.49M | 1972 |
| John Terence Rogers | Chief Financial Officer & Executive Director | 2.13M | 1969 |
| Emily Heaven | Head of Investor Relations | 0 | N/A |
| Charles Reynolds | Head of Corporate Communication | 0 | N/A |
| Vasant Padmanabhan | President Research & Development, ENT and Emerging Markets | 0 | 1967 |
| Ajay Dhankhar | Chief Corporate Development & Strategy Officer | 0 | 1971 |
| Paul Connolly | President of Global Operations | 0 | 1968 |
| Alison Parkes | Chief Compliance Officer & Compliance APAC | 0 | 1972 |
| Elga Lohler | Chief Human Resources Officer | 0 | 1968 |
| Helen Barraclough | Group General Counsel & Company Secretary | 0 | 1979 |
Description
Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction. This segment also provides trauma and extremities products, including internal and external fixation devices crucial for stabilizing severe fractures and correcting deformities. In the sports medicine field, the company furnishes surgeons with comprehensive joint repair solutions. These encompass specialized instruments, advanced technologies, and implants necessary for minimally invasive joint surgeries, addressing soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, its arthroscopic enabling technologies support surgical visualization and intervention inside joints, comprising fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, and monitors. It also supplies radiofrequency, electromechanical, and mechanical tissue resection devices, along with hand instruments for removing damaged tissue, and provides ear, nose, and throat (ENT) solutions. Furthermore, Smith & Nephew delivers sophisticated advanced wound management solutions. This category features products for the treatment and prevention of acute and chronic wounds, including leg, diabetic, and pressure ulcers, burns, and post-operative wounds. Its offerings extend to advanced wound bioactives, incorporating biologics and other active technologies for debridement, dermal repair, and regeneration, as well as regenerative medicine products like skin, bone graft, and articular cartilage substitutes. The advanced wound devices portfolio includes traditional and single-use negative pressure wound therapy systems, alongside hydrosurgery devices. Primarily serving healthcare providers, Smith & Nephew plc was founded in 1856 and maintains its corporate headquarters in Watford, United Kingdom.
